Tylenol Lawsuit News: Federal Judge Overseeing Tylenol Litigation Schedules February Status Conference, Bernstein Liebhard LLP Reports

The Firm is investigating Tylenol lawsuits on behalf of victims of acetaminophen-induced liver damage allegedly associated with the use of a Tylenol brand product.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm has received inquiries from numerous individuals who allegedly suffered severe liver damage following use of Tylenol-brand over-the-counter medication. We are very pleased to see this litigation moving forward.

New York, New York (PRWEB) January 22, 2014

Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered acetaminophen-induced liver damage due to the use of a Tylenol-brand medication continue to move forward in federal court, Bernstein Liebhard LLP reports. According to an Order issued on January 8, 2014, the federal judge overseeing the Tylenol multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, has scheduled the proceeding’s next status conference for February 18, 2014. The Order further stipulates that liaison counsel are to submit a written status report and agenda to the Court two business days before the conference. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Our Firm has received inquiries from numerous individuals who allegedly suffered severe liver damage following use of Tylenol-brand over-the-counter medication. We are very pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free Tylenol lawsuit reviews to victims of severe liver damage allegedly associated with the acetaminophen contained in Tylenol products.

Tylenol and Liver Damage
Court documents indicate that at least 120 lawsuits have been filed in the Eastern District of Pennsylvania that allege an association between the use of Tylenol and liver damage. According to these complaints, some plaintiffs claim to have suffered acetaminophen-induced liver damage so serious that it resulted in hospitalization, liver transplant, and even death. Plaintiffs further allege that these types of complications can occur even when Tylenol products are used in accordance with label directions.

In 2011, the U.S. Food & Drug Administration (FDA) announced that it would limit the amount of acetaminophen in prescription medications to 325 mg per tablet. According to a notice posted on the Federal Register, the new limits went into affect on January 14, 2014. In 2009, the FDA reported that acetaminophen was the leading cause of acute liver failure in the U.S. between 1998 and 2003.*

Last summer, Johnson & Johnson announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medications. According to a report published by Bloomberg.com at the time, bottles of Extra Strength Tylenol received the new labels in October, while other medications in the line are expected to follow. The report noted that Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA.**

Individuals who allegedly suffered acetaminophen-induced liver damage due to a Tylenol product may be entitled to compensation for medical bills, lost wages, pain and suffering, and other damages. To find out more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164897.pdf, FDA, 2009
**bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author